Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,289,304 | 4,289,304 | 0 | $79.44M | $82.23M | 48.17% | +$2.79M |
| Alumis Inc | 2,826,048 | 2,787,398 | -38,650 | $30.18M | $21.91M | 12.83% | -$8.27M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 614,594 | 539,194 | -75,400 | $24.58M | $18.55M | 10.87% | -$6.03M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $17.65M | $16.20M | 9.49% | -$1.45M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,519,971 | 1,519,971 | 0 | $23.48M | $15.32M | 8.98% | -$8.16M |
| Acelyrin Inc | 3,852,470 | 3,806,410 | -46,060 | $18.99M | $11.95M | 7.00% | -$7.04M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 7,102,190 | +7,102,190 | $0 | $4.55M | 2.66% | +$4.55M |